129 related articles for article (PubMed ID: 6608694)
1. Therapeutic potential of monovalent monoclonal antibodies.
Cobbold SP; Waldmann H
Nature; 1984 Mar 29-Apr 4; 308(5958):460-2. PubMed ID: 6608694
[TBL] [Abstract][Full Text] [Related]
2. Monoclonal antibodies to human lung tumor antigens demonstrated by immunofluorescence and immunoprecipitation.
Brenner BG; Jothy S; Shuster J; Fuks A
Cancer Res; 1982 Aug; 42(8):3187-92. PubMed ID: 7046919
[TBL] [Abstract][Full Text] [Related]
3. The improved lytic function and in vivo efficacy of monovalent monoclonal CD3 antibodies.
Clark M; Bindon C; Dyer M; Friend P; Hale G; Cobbold S; Calne R; Waldmann H
Eur J Immunol; 1989 Feb; 19(2):381-8. PubMed ID: 2522881
[TBL] [Abstract][Full Text] [Related]
4. Bi-specific monoclonal antibodies: selective binding and complement fixation to cells that express two different surface antigens.
Wong JT; Colvin RB
J Immunol; 1987 Aug; 139(4):1369-74. PubMed ID: 3112233
[TBL] [Abstract][Full Text] [Related]
5. Lymphocyte subsets and surface molecules in man.
Krensky AM; Lanier LL; Engleman EG
Clin Immunol Rev; 1985; 4(1):95-138. PubMed ID: 2992859
[No Abstract] [Full Text] [Related]
6. A clone specific monoclonal antibody which inhibits T cell-mediated cytolysis.
Lancki DW; Lorber MI; Loken MR; Fitch FW
Adv Exp Med Biol; 1982; 146():557-62. PubMed ID: 6808814
[No Abstract] [Full Text] [Related]
7. Nonrandom escape of tumor cells from immune lysis due to intraclonal fluctuations in antigen expression.
Taupier MA; Kearney JF; Leibson PJ; Loken MR; Schreiber H
Cancer Res; 1983 Sep; 43(9):4050-6. PubMed ID: 6871846
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of specific cell-mediated cytotoxicity by monoclonal antibodies to human T cell antigens.
Platsoucas CD; Good RA
Proc Natl Acad Sci U S A; 1981 Jul; 78(7):4500-4. PubMed ID: 6974866
[TBL] [Abstract][Full Text] [Related]
9. [Hybridomas synthesizing monoclonal antibodies to surface antigens of human lymphocytes].
Seregina TM; Mekshenkov MI
Tsitologiia; 1986 Sep; 28(9):976-80. PubMed ID: 3798564
[TBL] [Abstract][Full Text] [Related]
10. Monoclonal IgG3 (kappa) antibodies against murine Thy-1.2 antigen produced by murine hybridomas. Differences in the specificity of the antigen binding site and in the structure of the hinge region.
Zikán J; Dráber P; Vojtísková M
Folia Biol (Praha); 1982; 28(6):377-94. PubMed ID: 6186535
[TBL] [Abstract][Full Text] [Related]
11. Xenogeneic monoclonal antibodies to cell surface antigens of equine lymphocytes.
Newman MJ; Beegle KH; Antczak DF
Am J Vet Res; 1984 Apr; 45(4):626-32. PubMed ID: 6375479
[TBL] [Abstract][Full Text] [Related]
12. Production of Chinese hamster monoclonal antibody to a human cell-surface antigen using a hamster-human somatic cell hybrid as antigen.
Palmer DK; Jones C
Hybridoma; 1986; 5(3):249-53. PubMed ID: 3770776
[TBL] [Abstract][Full Text] [Related]
13. Characterization of rabbit cells by monoclonal and polyclonal antibodies.
Ponsard DC; Cinader B; Chou CT; Dubiski S
Immunology; 1986 Sep; 59(1):115-22. PubMed ID: 3489667
[TBL] [Abstract][Full Text] [Related]
14. Blocking of CTL-mediated killing by monoclonal antibodies to LFA-1 and Lyt-2, 3. II. Evidence that trypsin pretreatment of target cells removes a non-H-2 molecule important in killing.
Gromkowski SH; Heagy W; Martz E
J Immunol; 1985 Jan; 134(1):70-7. PubMed ID: 3880579
[TBL] [Abstract][Full Text] [Related]
15. [Monoclonal antibodies to the antigens of human HeLa tumor cells].
Malakhova IV; Khizhniakova TM; Novokhatskiĭ AS
Tsitologiia; 1986 May; 28(5):537-44. PubMed ID: 3526672
[TBL] [Abstract][Full Text] [Related]
16. Human T cells resistant to complement lysis by bivalent antibody can be efficiently lysed by dimers of monovalent antibody.
Nielsen SU; Routledge EG
Blood; 2002 Dec; 100(12):4067-73. PubMed ID: 12393711
[TBL] [Abstract][Full Text] [Related]
17. A rapid screening technique for monoclonal antibodies with specificity for protein antigens.
Holmberg D; Ivars F; Edlund T
J Immunol Methods; 1983 Jun; 61(1):9-16. PubMed ID: 6406612
[TBL] [Abstract][Full Text] [Related]
18. The use of hybrid hybridomas to target human cytotoxic T lymphocytes.
Lanzavecchia A; Scheidegger D
Eur J Immunol; 1987 Jan; 17(1):105-11. PubMed ID: 3102250
[TBL] [Abstract][Full Text] [Related]
19. Monoclonal antibodies to human prostate and bladder tumor-associated antigens.
Starling JJ; Sieg SM; Beckett ML; Schellhammer PF; Ladaga LE; Wright GL
Cancer Res; 1982 Aug; 42(8):3084-9. PubMed ID: 7046915
[TBL] [Abstract][Full Text] [Related]
20. Monoclonal antibodies against leucoagglutinin-reactive human T lymphocyte surface components. Two antibodies which inhibit cell-mediated cytotoxicity at a post-binding stage.
Vargas-Cortes M; Hammarström ML; Hammarström S; Hellström U; Perlmann P
Eur J Immunol; 1986 Jul; 16(7):795-801. PubMed ID: 3522246
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
